Enjoy complimentary customisation on priority with our Enterprise License!
The periodontal therapeutics market share is expected to increase by USD 120.80 million from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 6%.
This periodontal therapeutics market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers market segmentations by product (Local antibiotics and Systemic antibiotics) and geography (North America, Europe, Asia, and ROW). The periodontal therapeutics market report also offers information on several market vendors, including 3M Co., Bausch Health Companies Inc., Cadila Healthcare Ltd., Den-Mat Holdings LLC, Dexcel Pharma Technologies Ltd., KAKEN PHARMACEUTICAL CO. LTD., Pfizer Inc., Straumann Holding AG, Sunstar Suisse SA, and Teva Pharmaceutical Industries Ltd. among others.
Download the Free Report Sample to Unlock the Periodontal Therapeutics Market Size for the Forecast Period and Other Important Statistics
Based on our research output, there has been a neutral impact on the market growth during and post COVID-19 era. The rising prevalence of periodontal diseases is notably driving the periodontal therapeutics market growth, although factors such as development of antibiotic resistant bacterial strain may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the periodontal therapeutics industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Driver for the Periodontal Therapeutics Market
The rising prevalence of periodontal diseases is one of the key drivers for the market in focus. Periodontal are prevalent in both developed and developing countries and affect individuals irrespective of their age, thus, making them a public health concern. Periodontal diseases have evolved as the most common oral condition in human beings globally. With the rising global prevalence of periodontal diseases, there will be an increased demand for periodontal drugs, which will drive the market's growth during the forecast period.
Key Periodontal Therapeutics Market Challenge
The development of antibiotic-resistant bacterial strains is one of the challenges for the market in focus. Patients with chronic periodontitis often yield various types of bacterial strains that may vary in their susceptibility toward antibiotic therapy. Several studies have been conducted to evaluate the susceptibility of selected subgingival periodontal pathogens toward antibiotics in patients with chronic periodontitis. Globally, antibiotic resistance among patients with chronic periodontitis is increasing at an alarming rate. Thus, making the antibiotic less effective in treating the diseases, thereby decreasing the use of antibiotics among these patients. The decreased consumption of antibiotics hinders the growth prospects of the market.
This periodontal therapeutics market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the periodontal therapeutics market encompasses successful business strategies deployed by the key vendors. The periodontal therapeutics market is fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The periodontal therapeutics market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
For more insights on the market share of various regions Request for a FREE sample now!
40% of the market's growth will originate from North America during the forecast period. The US is the key country for the periodontal therapeutics market in North America. Market growth in this region will be faster than the growth of the market in Europe and ROW.
The increasing patient pool with periodontal diseases will facilitate the periodontal therapeutics market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
To gain further insights on the market contribution of various segments Request for a FREE sample
The periodontal therapeutics market share growth by the local antibiotics segment will be significant during the forecast period. The high market share is attributed to the increased use of local antibiotics for the treatment of periodontal diseases. These drugs offer targeted delivery, which increases the bioavailability of drugs and improves pharmacologic effects. The adoption of local antibiotics to achieve the desired response contributes to the growth of the segment.
This report provides an accurate prediction of the contribution of all the segments to the growth of the periodontal therapeutics market size and actionable market insights on post COVID-19 impact on each segment.
|
Periodontal Therapeutics Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
120 |
|
Base year |
2020 |
|
Forecast period |
2021-2025 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 6% |
|
Market growth 2021-2025 |
$ 120.80 million |
|
Market structure |
Fragmented |
|
YoY growth (%) |
6.01 |
|
Regional analysis |
North America, Europe, Asia, and ROW |
|
Performing market contribution |
North America at 40% |
|
Key consumer countries |
US, Germany, France, UK, and Japan |
|
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
|
Key companies profiled |
3M Co., Bausch Health Companies Inc., Cadila Healthcare Ltd., Den-Mat Holdings LLC, Dexcel Pharma Technologies Ltd., KAKEN PHARMACEUTICAL CO. LTD., Pfizer Inc., Straumann Holding AG, Sunstar Suisse SA, and Teva Pharmaceutical Industries Ltd. |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Product
Customer landscape
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Certified ISO 9001 : 2015
We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.
We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.
Get lifetime access to our
Technavio Insights
Customized Report as per your Business Needs
Let us help you make report more suited to your requirements.
Get the report (PDF) sent to your email within minutes.
